High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies. - Wikidata - awgldk - TriplyDB

High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.

High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.

http://www.wikidata.org/entity/Q33425245

about

Critical appraisal of eculizumab for atypical hemolytic uremic syndrome Complete remission of thrombotic microangiopathy after treatment with eculizumab in a patient with non-Shiga toxin-associated bacterial enteritis: A case report.Anti-complement-factor H-associated glomerulopathies.The Genetics of Ultra-Rare Renal Disease.Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense Routine use of clinical exome-based next-generation sequencing for evaluation of patients with thrombotic microangiopathies.C3 glomerulopathy.Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.Targeted exome sequencing in anti-factor H antibody negative HUS reveals multiple variations.Diseases of complement dysregulation-an overview.C3 glomerulonephritis and thrombotic microangiopathy of renal allograft after pulmonary infection in a male with concomitant two complement factor I gene variations: a case report.

P2860

Q26750692-322A0C4B-7781-4EE6-A39D-D058199BC4E0 Q33433788-431754CD-91DB-43E4-A405-94409589A2D1 Q33434103-C88DD925-A3DA-42D4-B279-A7E01F992D1F Q37032691-0157C0EE-802D-418D-B6B1-D0A36A5517CF Q38558926-32A37A0A-D3EE-4615-9835-A31FDEFCC3F2 Q38655720-E250ABD6-654F-4CBA-8E10-0DD4C7D4D6B8 Q39207807-52D5C340-50C8-4F8F-BE3A-BE8AD021D1D5 Q47640137-B33AE658-6A3E-46B1-A8CF-AA844F31E869 Q47909388-A960F4A6-522F-44A2-A707-ED2A39682F2D Q47937936-A2E1F156-FF18-489E-85E1-13AA9109FF74 Q48256943-9E2C1633-AEE6-4671-8D24-F2F33D76FD56 Q55447429-EA8462CF-B470-4616-BDF1-BDDE40CF7C24

P2860

High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.

http://www.wikidata.org/entity/Q33425245

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.

@ast

High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.

@en

type

label

High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.

@ast

High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.

@en

prefLabel

High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.

@ast

High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.

@en

P1433

Q33425245-F63C4202-9B54-4A2C-A4C1-E49244ED0114

P1476

Q33425245-5B39F7EB-BACF-4135-8266-17DFCF62D29F

P2093

Q33425245-71149251-C1EF-456A-BF42-793B907A3345

Q33425245-74FEA564-A4B0-4FFD-97EC-67003559B790

Q33425245-794E78D3-2C3C-446B-AF0F-9A269B7660D6

Q33425245-7D076599-ABC5-4AE0-8C94-33BFC7C1E6E1

Q33425245-85AB37D2-2496-4BD5-9B7F-14304C88BD45

Q33425245-9C82091D-050D-494A-8D7E-004F8C610F0F

Q33425245-9E856921-8B7D-4BF7-A2EF-34308CA5FC06

Q33425245-BDC8C277-B936-4BD0-9EEA-1B236BFB7460

Q33425245-C22FE899-13FE-4BE1-9E8E-77EFD2426F93

Q33425245-E1CA4EF9-EABB-4098-95B5-7CD694243655

P2860

Q33425245-05CB30CA-06CB-4692-8CDD-315AA3652793

Q33425245-0D0BD951-27E9-4580-810A-ABAFF7B2C0A8

Q33425245-11637FCD-6AE4-47AC-8C43-C23819602EA6

Q33425245-1C1D7606-BB6D-46F6-B990-2C9748A3F63F

Q33425245-1F50F3DC-C2CF-4465-B964-4B90DD22DD1B

Q33425245-1FC93E88-C999-40E6-9A18-E62363518FC8

Q33425245-2B6EBD5B-698B-4D6A-BDF9-B81C4C159375

Q33425245-3DA5FC78-B2A7-4E4C-8213-15B268F2AA88

Q33425245-45760C3F-AB16-4C1E-AEFC-D5F38482F0F9

Q33425245-51D1CB36-9A5D-4BC0-9715-CF113CCBA278

P304

Q33425245-F66B401C-3168-4982-AFF5-AA5854EA0A48

P31

Q33425245-0E6D00C4-689B-4D11-B28E-D332825BDAFF

P356

Q33425245-F78CD5B1-9BC7-47BE-9F51-8AD30B64D2A5

P433

Q33425245-FB2813AF-A0CE-43FF-A7FC-1908A933A283

P478

Q33425245-A5E99CED-4312-40FD-AE7C-F56501F9DD75

P50

Q33425245-5EF1358B-AC66-46B4-ACCC-CF496D6FB79A

Q33425245-5FBCC7EB-183A-4F94-BFA3-9C58D9C658B9

Q33425245-6FE154E9-F1D4-439E-AC67-1673ADB8D863

P577

Q33425245-03193DDD-50B8-4F1C-9AF8-50E4758E7923

P5875

Q33425245-DAF77797-E5D0-455B-9B15-518B7E6F14C8

P698

Q33425245-5D25B9FA-286A-4AEB-877B-A622569D21AD

P932

Q33425245-C2A9F59B-CC1D-471D-A922-4A034D12B9CA

P356

P1433

Journal of the American Society of Nephrology

P1476

High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.

@en

P2093

Carla Nester

http://www.w3.org/2001/XMLSchema#string

Carla Nishimura

http://www.w3.org/2001/XMLSchema#string

Diana L Kolbe

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Black-Ziegelbein

http://www.w3.org/2001/XMLSchema#string

Erika Takanami

http://www.w3.org/2001/XMLSchema#string

Hela Azaiez

http://www.w3.org/2001/XMLSchema#string

Jill J Hauer

http://www.w3.org/2001/XMLSchema#string

Kathy Frees

http://www.w3.org/2001/XMLSchema#string

Michael B Jones

http://www.w3.org/2001/XMLSchema#string

Michael J Schnieders

http://www.w3.org/2001/XMLSchema#string

P2860

A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

A method and server for predicting damaging missense mutations

Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

Distribution and intensity of constraint in mammalian genomic sequence

Exome sequencing as a tool for Mendelian disease gene discovery

Advancing genetic testing for deafness with genomic technology.

The Polarizable Atomic Multipole-based AMOEBA Force Field for Proteins.

Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

P304

1245-1253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2015040385

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Richard J Smith

Christie Thomas

P577

2015-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281098751

http://www.w3.org/2001/XMLSchema#string

P698

26283675

http://www.w3.org/2001/XMLSchema#string

P932

4814193

http://www.w3.org/2001/XMLSchema#string